Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBC

Clinical trial NCT06700382 · RECRUITING

Trial details

NCT number: NCT06700382
Sponsor: Shu Wang
Status: RECRUITING
Study type: OBSERVATIONAL

Triple Negative Breast Cancer

Start date: 2019-01-01
Primary completion: 2031-12-31
Enrollment: 1166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.